NCT00385411View on ClinicalTrials.gov

Study of Valproate in Young Patients Suffering From Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Epilepsy
Interventions
DRUG

valproate microgranules

20 to 30 mg/kg/day

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00385411 - Study of Valproate in Young Patients Suffering From Epilepsy | Biotech Hunter | Biotech Hunter